天弘中证医药主题指数增强A(012401)财务指标
| |
2025-12-31 |
2025-06-30 |
2024-12-31 |
2024-06-30 |
| 本期已实现收益 |
1,674,832.33 |
-450,854.42 |
-8,871,562.57 |
-5,239,952.33 |
| 本期利润 |
2,945,683.59 |
1,414,182.34 |
-8,233,698.35 |
-9,275,379.13 |
| 加权平均基金份额本期利润 |
0.06 |
0.03 |
-0.13 |
-0.14 |
| 本期加权平均净值利润率(%) |
8.75 |
3.89 |
-18.63 |
-20.31 |
| 本期基金份额净值增长率(%) |
7.98 |
4.36 |
-15.51 |
-18.23 |
| 期末可供分配利润 |
-12,060,532.48 |
-14,979,000.59 |
-22,326,330.19 |
-25,111,101.51 |
| 期末可供分配基金份额利润 |
-0.30 |
-0.32 |
-0.35 |
-0.37 |
| 期末基金资产净值 |
28,585,289.35 |
31,780,991.96 |
41,704,114.46 |
42,837,051.34 |
| 期末基金份额净值 |
0.70 |
0.68 |
0.65 |
0.63 |
| 基金份额累计净值增长率(%) |
-29.67 |
-32.03 |
-34.87 |
-36.96 |